Current approaches of nanomedicines in the market and various stage of clinical translation.

Shan X, Gong X, Li J, Wen J, Li Y, Zhang Z.

Open source

DOI
10.1016/j.apsb.2022.02.025
Published
2022-03-01
Container
Acta Pharm Sin B
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.apsb.2022.02.025,
  title = {Current approaches of nanomedicines in the market and various stage of clinical translation.},
  author = {Shan X and  Gong X and  Li J and  Wen J and  Li Y and  Zhang Z.},
  year = {2022},
  journal = {Acta Pharm Sin B},
  doi = {10.1016/j.apsb.2022.02.025},
  url = {https://doi.org/10.1016/j.apsb.2022.02.025}
}

RIS

TY  - JOUR
TI  - Current approaches of nanomedicines in the market and various stage of clinical translation.
AU  - Shan X
AU  -  Gong X
AU  -  Li J
AU  -  Wen J
AU  -  Li Y
AU  -  Zhang Z.
PY  - 2022
JO  - Acta Pharm Sin B
DO  - 10.1016/j.apsb.2022.02.025
UR  - https://doi.org/10.1016/j.apsb.2022.02.025
ER  -

APA

X, S., X, G., J, L., J, W., Y, L., & Z., Z. (2022). Current approaches of nanomedicines in the market and various stage of clinical translation.. Acta Pharm Sin B. https://doi.org/10.1016/j.apsb.2022.02.025

Source records